Cerity Partners’s Journey Medical DERM Stock Holding History

Cerity Partners’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,421	Closed	-$48.8M	–	1722
2023 Q1	$48.8M	Hold	25,421	–	–	0.12%	133
2022 Q4	$48.8K	Hold	25,421	–	–	﹤0.01%	1434
2022 Q3	$63K	Buy	+25,421	New	+$86.7K	﹤0.01%	1132

Other funds holding DERM

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Cerity Partners's DERM Position: Q2 2023 in Review

Cerity Partners sold out of Journey Medical (DERM) in Q2 2023, closing a stake of 25,421 shares — an estimated $48.8M sold.

Cerity Partners first reported a position in DERM in Q3 2022 and held it in 3 quarters. The position peaked at $48.8M in Q1 2023. 20 funds tracked by Wall St. Rank hold DERM as of Q2 2023.

Cerity Partners reported no remaining Journey Medical position as of Q2 2023 after selling out during the quarter.
Cerity Partners sold 25,421 Journey Medical shares in Q2 2023, an estimated $48.8M.
Cerity Partners first reported a position in Journey Medical in Q3 2022 and held it in 3 quarters.
Cerity Partners's Journey Medical position peaked at $48.8M in Q1 2023.
20 funds tracked by Wall St. Rank held Journey Medical as of Q2 2023.

Based on Cerity Partners's 13F filing for Q2 2023, filed 14 Aug 2023.